PI3K protein: Potential new therapeutic target in pancreatic neuroendocrine tumors
Friday, June 17, 2016 - 11:31
in Health & Medicine
Researchers have demonstrated that selective inactivation of the p110&alpha, PI3K isoform is sufficient to block tumor progression and metastasis in a mice model of PanNETs